NEWAMSTERDAM PHARMA COMPANY

Ticker: NAMS CUSIP: N62509109 Class: Stock

Alyeska Investment Group, L.P.'s Holding History (CIK: 0001453072)

Note: Option positions (PUT/CALL) are excluded.

Q4 2024

Shares 114,707 Value ($000) $2,948 Avg Close $21.24 Range $15.51 - $27.29

Q3 2024

Shares 308,158 Value ($000) $5,115 Avg Close $17.30 Range $15.19 - $21.48

Q2 2024

Shares 85,641 Value ($000) $1,645 Avg Close $20.06 Range $16.62 - $24.79

Q1 2024

Shares 35,641 Value ($000) $843 Avg Close $20.30 Range $11.18 - $26.35

Q3 2023

Shares 44,432 Value ($000) $411 Avg Close $10.83 Range $8.57 - $12.54

Q2 2023

Shares 129,547 Value ($000) $1,540 Avg Close $13.27 Range $11.03 - $17.00

Q4 2022

Shares 200,000 Value ($000) $1,892 Avg Close $9.95 Range $7.52 - $32.88

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2024	114,707	$2,948	$21.24	$15.51 - $27.29
Q3 2024	308,158	$5,115	$17.30	$15.19 - $21.48
Q2 2024	85,641	$1,645	$20.06	$16.62 - $24.79
Q1 2024	35,641	$843	$20.30	$11.18 - $26.35
Q3 2023	44,432	$411	$10.83	$8.57 - $12.54
Q2 2023	129,547	$1,540	$13.27	$11.03 - $17.00
Q4 2022	200,000	$1,892	$9.95	$7.52 - $32.88